Orchid Pharma Ltd (ORCHPHARMA) Stock Price & News

Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia

About Orchid Pharma Ltd

CEO-

Employees1,17 ათ.

Founded1992

Headquarters-

SectorPharmaceutical industry

Websiteorchidpharma.com

All values in INR	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	1,94 მლრდ.	2,07 მლრდ.	6,59 მლრდ.	3,04 მლრდ.
Cost of goods sold	1,33 მლრდ.	1,43 მლრდ.	5,03 მლრდ.	2,04 მლრდ.
Cost of revenue	1,33 მლრდ.	1,43 მლრდ.	5,03 მლრდ.	2,04 მლრდ.
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	248,51 მლნ.	241,28 მლნ.	502,27 მლნ.	280,38 მლნ.
Operating expense	713,95 მლნ.	715,86 მლნ.	1,40 მლრდ.	968,16 მლნ.
Total operating expenses	2,04 მლრდ.	2,15 მლრდ.	6,43 მლრდ.	3,01 მლრდ.
Operating income	-103,77 მლნ.	-74,65 მლნ.	163,81 მლნ.	30,51 მლნ.
Other non operating income	107,74 მლნ.	56,09 მლნ.	-238,03 მლნ.	18,28 მლნ.
EBT including unusual items	-57,24 მლნ.	-126,14 მლნ.	131,94 მლნ.	32,97 მლნ.
EBT excluding unusual items	-57,24 მლნ.	-55,01 მლნ.	54,86 მლნ.	32,97 მლნ.
Income tax expense	-	-	17,00 ათ.	723,00 ათ.
Effective tax rate	-	-	0,01%	2,19%
Other operating expenses	376,43 მლნ.	384,29 მლნ.	419,31 მლნ.	578,29 მლნ.
Net income	-57,24 მლნ.	-126,14 მლნ.	131,92 მლნ.	32,24 მლნ.
Net profit margin	-2,96%	-6,09%	2,00%	1,06%
Earnings per share	-1,13	-1,08	4,58	0,54
Interest and investment income	-	-	101,25 მლნ.	-
Interest expense	-37,32 მლნ.	-31,78 მლნ.	-	-22,30 მლნ.
Net interest expenses	-37,32 მლნ.	-31,78 მლნ.	101,25 მლნ.	-22,30 მლნ.
Depreciation and amortization charges	89,01 მლნ.	90,29 მლნ.	166,61 მლნ.	109,49 მლნ.
EBITDA	-15,99 მლნ.	10,45 მლნ.	269,63 მლნ.	119,14 მლნ.
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything